How to Find an Expert in Hereditary Breast & Ovarian Cancer
At a Glance
To find an expert in Hereditary Breast and Ovarian Cancer, look for an NCI-Designated Cancer Center or a dedicated High-Risk Genetics Clinic. These centers feature multidisciplinary teams that follow the latest NCCN guidelines for specialized screening and risk-reducing surgeries.
Finding a doctor who truly understands Hereditary Breast and Ovarian Cancer (HBOC) syndrome means looking beyond a general oncologist or standard OB-GYN. Because medical knowledge about genetic mutations evolves rapidly, you need a provider or clinic that specializes specifically in hereditary cancer risk. The most reliable way to find this level of expertise is to seek care at a National Cancer Institute (NCI)-Designated Cancer Center or a dedicated High-Risk Genetics Clinic [1]. These centers focus on the specific, rigorous surveillance and prevention guidelines required for people with mutations like BRCA1, BRCA2, and other genes linked to cancer.
Why You Need a Hereditary Cancer Expert
General practitioners and standard oncologists treat a wide variety of conditions, which means they might not be fully up-to-date on the niche, highly specific guidelines for hereditary cancer syndromes. An expert in HBOC will base their care on the most recent NCCN (National Comprehensive Cancer Network) guidelines, which dictate exactly when and how often you need breast screenings (like breast MRIs) and the optimal timing for risk-reducing surgeries for your ovaries [2][3].
Furthermore, true experts understand that not all genetic mutations carry the same risks. They will tailor your care based on the specific gene involved (for example, distinguishing the care plan for a gene with a very high lifetime risk of cancer like BRCA1 versus a gene with a moderate risk like CHEK2) [2][3].
Quality Indicators of a Top-Tier Clinic
When vetting a medical center or provider, look for these hallmarks of high-quality hereditary cancer care:
- A Multidisciplinary Team: The clinic should have a coordinated team that includes breast surgical oncologists, gynecologic oncologists, medical geneticists, and radiologists who specialize in high-risk imaging [4][1].
- Dedicated Genetic Counselors: Access to certified genetic counselors is essential for interpreting genetic test results accurately and discussing cascade testing (the process of testing your at-risk family members) [5][6].
- Long-term Surveillance Navigation: High-quality clinics often provide a systematic, long-term plan to ensure you don’t miss closely spaced screenings [7].
- Comprehensive Psychosocial Support: Carrying a genetic mutation can be incredibly stressful. Expert clinics incorporate psychological support to help manage anxiety, depression, and the complex impacts of risk-reducing surgeries, such as early menopause and sexual health changes [8][9].
Navigating Access, Telehealth, and Insurance
Not everyone lives near a major NCI-Designated Cancer Center, but you can still access expert care. Many specialized genetics clinics and genetic counselors now offer telehealth or remote consultations [1]. Often, you can consult with an expert at a major center virtually to create a personalized, NCCN-guided surveillance plan, and then have your local oncologist or OB-GYN carry out the routine screenings locally.
When you first contact a specialized center, you will typically need a referral from your primary care doctor, OB-GYN, or general oncologist. Be sure to call your health insurance provider to confirm that the specialized clinic is in-network for your plan, and ask if they cover genetic counseling and high-risk surveillance under your specific policy.
How to Start Your Search
You can begin by checking the directory of NCI-Designated Cancer Centers, which are recognized for their scientific excellence and multidisciplinary care. Additionally, the National Society of Genetic Counselors (NSGC) offers a “Find a Genetic Counselor” tool to help you locate professionals who specialize in cancer genetics in your area [10]. Patient advocacy organizations, such as FORCE (Facing Our Risk of Cancer Empowered), also provide resources and community recommendations for finding high-risk specialists.
Common questions in this guide
Why do I need a specialist for Hereditary Breast and Ovarian Cancer?
What should I look for in a high-risk genetics clinic?
Can I get expert hereditary cancer care if I don't live near a major center?
How do I start my search for a hereditary cancer expert?
What questions should I ask a new doctor about managing my genetic mutation?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Are you and your clinic regularly updating patient care plans based on the latest NCCN guidelines for hereditary cancer?
- 2.Approximately how many patients with my specific genetic mutation (e.g., BRCA1, BRCA2, PALB2) do you manage each year?
- 3.Does your clinic provide a multidisciplinary approach, and which specialists (such as genetic counselors or gynecologic oncologists) are part of the core team?
- 4.Do you offer a formal, long-term surveillance plan that coordinates all of my high-risk screenings throughout the year?
- 5.How does your team support the psychosocial aspects of carrying a genetic mutation, such as managing anxiety or sexual health after preventive surgeries?
- 6.Are you comfortable coordinating with my local doctors to execute my surveillance plan if I live far from your center?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (10)
- 1
How I approach hereditary cancer predisposition in a child with cancer.
Kuhlen M, Wieczorek D, Siebert R, Frühwald MC
Pediatric blood & cancer 2019; (66(11)):e27916 doi:10.1002/pbc.27916.
PMID: 31342632 - 2
Beyond BRCA: Review of Hereditary Syndromes Predisposing to Breast Cancer.
Nguyen JV, Thomas MH
Journal of breast imaging 2019; (1(2)):84-91 doi:10.1093/jbi/wbz014.
PMID: 38424924 - 3
Principles of molecular testing for hereditary cancer.
Mighton C, Lerner-Ellis JP
Genes, chromosomes & cancer 2022; (61(6)):356-381 doi:10.1002/gcc.23048.
PMID: 35436018 - 4
Pathology of Hereditary Breast and Ovarian Cancer.
Hodgson A, Turashvili G
Frontiers in oncology 2020; (10()):531790 doi:10.3389/fonc.2020.531790.
PMID: 33117676 - 5
Next-Generation Gene Sequencing: Looking Beyond Hereditary Breast and Ovarian Cancer.
Estrada SS, LeGrazie B, McKamie T, Montgomery S
Oncology nursing forum 2015; (42(6)):691-4 doi:10.1188/15.ONF.691-694.
PMID: 26488839 - 6
Cancer Predisposition in Neonates and Infants: Recognition, Tumor Types, and Surveillance.
Mitchell SG, Pencheva B, Westfall E, Porter CC
Clinics in perinatology 2021; (48(1)):1-14 doi:10.1016/j.clp.2020.11.001.
PMID: 33583498 - 7
Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
Shao D, Cheng S, Guo F, et al.
Cancer science 2020; (111(2)):647-657 doi:10.1111/cas.14242.
PMID: 31742824 - 8
Understanding patient priorities: Sexual health and hereditary ovarian cancer syndromes.
Perez L, Kulkarni A, Lopez S, et al.
Gynecologic oncology 2026; (205()):113-119 doi:10.1016/j.ygyno.2025.12.010.
PMID: 41619425 - 9
How does genetic testing influence anxiety, depression, and quality of life? A hereditary breast and ovarian cancer syndrome suspects trial.
Oliveira FFB, de Barros Silva PG, de Sant'Ana RO, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2021; (29(7)):3521-3530 doi:10.1007/s00520-020-05867-2.
PMID: 33155091 - 10
Cascade Genetic Testing for Hereditary Cancer Predisposition: Characterization of Patients in a Catchment Area of Southern Italy.
Bilotta A, Lo Feudo E, Rocca V, et al.
Genes 2025; (16(7)) doi:10.3390/genes16070795.
PMID: 40725451
This page is for informational purposes only and does not replace professional medical advice. Always consult a specialized healthcare provider or genetic counselor regarding your hereditary cancer risk and surveillance plan.
Get notified when new evidence is published on Hereditary breast and/or ovarian cancer syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.